SI SHOULDER INNOVATIONS, INC.
Debt Financing ·
Shoulder Innovations signed a $15.0 million senior secured term loan with Stifel Bank on June 26, 2026, and used it to repay Trinity Capital. The $30.0 million asset-based revolver was undrawn at closing.
We have not published a story on SHOULDER INNOVATIONS, INC. yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $47.3 million | $31.6 million |
| Research and development | $7.7 million | $4.5 million |
| Net income (loss) | -$40.4 million | -$15.6 million |
| Cash from operations | -$28.6 million | -$14.1 million |
| Cash and equivalents | $26.9 million | $6.1 million |
| Short-term investments | $97.4 million | $8.9 million |
SHOULDER INNOVATIONS, INC. trades under the ticker SI on NYSE.
SHOULDER INNOVATIONS, INC. is listed on NYSE.
Our directory records SHOULDER INNOVATIONS, INC. under United States.
aibio.space lists SHOULDER INNOVATIONS, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
$47.3 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
SHOULDER INNOVATIONS, INC. reported a net loss of $40.4 million for the fiscal year ended Dec 31, 2025, and used $28.6 million of cash in operations, per its annual report to the SEC.
$7.7 million in the fiscal year ended Dec 31, 2025, per its annual report.
$99.0 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Our latest story on SHOULDER INNOVATIONS, INC., dated Jun 26, 2026: "Shoulder Innovations takes $15.0 million Stifel term loan, repays Trinity". Shoulder Innovations signed a $15.0 million senior secured term loan with Stifel Bank on June 26, 2026, and used it to repay Trinity Capital. The $30.0 million asset-based revolver was undrawn at closing. Source.
Our latest debt story, dated Jun 26, 2026: "Shoulder Innovations takes $15.0 million Stifel term loan, repays Trinity". Shoulder Innovations signed a $15.0 million senior secured term loan with Stifel Bank on June 26, 2026, and used it to repay Trinity Capital. The $30.0 million asset-based revolver was undrawn at closing. Source.
Press Follow on this page to add SHOULDER INNOVATIONS, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming SHOULDER INNOVATIONS, INC. so far, in Debt Financing.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio